Abstract
Serum calcium, albumin, phosphorus, and alkaline phosphatase, urinary creatinine and retention of 99mTc-methylene bisphosphonate (99mTc-MDP) were measured in 61 subjects with osteoporosis and the values compared with those obtained in normal subjects. 99mTc-MDP retention was inversely related with urinary creatinine output in normal subjects. In osteoporotic subjects urinary creatinine output was lower and 99mTc-MDP retention higher even when urinary creatinine output was taken into account. Other measurements were similar. In 21 subjects these measurements together with urinary hydroxyproline were performed before and after treatment with calcium and vitamin D. 99mTc-MDP and alkaline phosphatase fell; urinary hydroxyproline was unchanged. A single 24 h urine measurement after 99mTc-MDP injection is a valuable method of predicting whether calcium and vitamin D therapy will be useful in a particular case of osteoporosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abraham RR, Wynn V (1987) Reduction in resting energy expenditure in relation to lean tissue loss in obese subjects during prolonged dieting. Ann Nutr Metab 31:98–108
Avioli LV, MacDonald JE (1965) The influence of age on the intestinal absorption of 47Ca in women and its relation to 47Ca absorption in postmenopausal osteoporosis. J Clin Invest 44:1960–1967
Berlyne GM, Ben AJ, Kushelevesky A, Idelman A, Galinsky D, Hirsch M, Shainkin R, Yagil R, Zlotnick M (1975) The aetiology of senile osteoporosis: Secondary hyperparathyroidism due to renal failure. Quart J Med 44:505–521
Caniggia A, Vattimo A (1980) Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: A simple index of bone metabolism. Calcif Tissue Int 30:5–13
Daniell HW (1976) Osteoporosis of the slender smoker. Arch Int Med 136:298–304
Davie MWJ, Abraham RR, Hewins B, Wynn V (1986) Changes in bone and muscle constituents during dieting for obesity. Clin Sci 70:285–293
Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig RG (1978) The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 19:270–275
Fogelman I (1980) Skeletal uptake of diphosphonate: A review. Eur J Nucl Med 5:473–476
Fogelman I, Bessent RG, Beastall G, Boyle IT (1980a) Estimation of skeletal involvement in primary hyperparathyroidism. Ann Int Med 92:65–67
Fogelman I, Bessent RG, Cohen HN, Hart DM, Lindsay R (1980b) Skeletal Uptake of Diphosphonate. Lancet ii:667–670
Fogelman I, Citrin DL, Bessent RG, Mazess R (1980c) The development and validation of measurement of 24-h bone uptake of 99mTc HEDP as an index of metabolic bone disease. NIH Publ 80:447–453
Fogelman I, Bessent R (1982) Age-related alteration in skeletal metabolism-24 h whole body retention of diphosphonate in 250 normal subjects: Concise communication. J Nucl Med 23:296–300
Forbes GB, Bruining GJ (1976) Urinary creatinine excretion and lean body mass. Am J Clin Nutr 29:1356–1366
Hyldstrup L, Mogensen N, Jensen GF, McNair P, Transbol I (1984a) Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism. Scand J Clin Lab Invest 44:105–109
Hyldstrup L, McNair P, Jensen GF, Mogensen NB, Transbol I (1984b) Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals; dependency on age sex and glomerular filtration. Scand J Clin Lab Invest 44:673–678
Hyldstrup L, McNair P, Jensen GF, Transbol I (1986) Seasonal variations in indices of bone formation precede appropriate bone mineral changes in normal men. Bone 7:167–170
Jensen GF (1986) Osteoporosis of the slender smoker revisited by epidemiologic approach. Eur J Clin Invest 16:239–242
Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC (1976) Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet i:1038–1040
Macfarlane JD, Khairi MRA, Ricciardone M, Wellman HN, Johnston CC (1979) Renal excretion of 99mTc-diphosphonate in osteomalacia. Ann Int Med 90:350–351
Meunier PJ, Sellami S, Briancour D, Edouard C (1981) Histological heterogeneity of apparently idiopathic osteoporosis. In: De Luca HF, Dehuca HF, Frost HN, Jee WSS, Johnston CC, Parfitt AM (eds) Ostcoporosis: Recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 293–301
Nordin BEC, Horsman A, Crilly RG, Marshall DH, Simpson M (1980) Treatment of spinal osteoporosis in postmenopausal women. Br Med J i:451–454
Riggs BL, Seeman E, Hodgson SF, Taves RD, O'Fallon WM (1982) Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med 306:446–450
Thomsen K, Nilas L, Mogenson T, Christiansen C (1986) Determination of bone turnover by urinary excretion of 99mTc-MDP. Eur J Nucl Med 12:342–345
Webster SGP, Leeming JT (1975) Assessment of small bowel function in the elderly using a modified xylose tolerance test. Gut 16:109–113
Whyte MP, Bergfeld MA, Murphy WA, Avioli LV, Teitelbaum SL (1982) Post menopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients. Am J Med 72:793–202
Wiske PS, Epstein S, Bell NH, Queener SF, Edmondson J, Johnston CC (1979) Increases in immunoreactive parathyroid hormone with age. N Engl J Med 300:1419–1421
Woessner JF (1961) The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440–447
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davie, M.W.J., Britton, J.M., Haddaway, M. et al. 99mTc-MDP retention in osteoporosis: Relationship to other indices of bone cell activity and response to calcium and vitamin D therapy. Eur J Nucl Med 13, 462–466 (1987). https://doi.org/10.1007/BF00281861
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00281861